Introduction
The organization of genomic DNA into chromatin aids in the regulation of gene expression by limiting the access of transcriptional binding domains (Pazin and Kadonaga, 1997) . The SWI/SNF family of proteins, ®rst discovered in S. cerevisiae, contains a number of proteins including SWI2/SNF2, SWI3, SNF5 and SNF6. Named for yeast mating type switching (SWI) and sucrose non-fermenting (SNF), these proteins have been shown to be required for expression of a number of genes in yeast including ADH1, ADH2, SUC2, GAL1 and GAL4. It has been postulated that chromatin is remodeled by an interaction with the SWI/SNF complex resulting in an increase in transcription (Cairns et al., 1994; Cote et al., 1994; Kwon et al., 1994; Pazin and Kadonaga, 1997; Peterson and Herskowitz, 1992) .
Each SWI/SNF protein is required for the function of the entire complex. Single and double mutations in the SWI/SNF proteins result in a similar phenotype in yeast. Increasing the amount of one protein does not compensate for the lack of another. This interdependence is perhaps due to the necessity for proper formation of the SWI/SNF complex (Laurent et al., 1991; Peterson and Herskowitz, 1992; Wang et al., 1996a) . Further evidence that the SWI/SNF proteins form a complex has been demonstrated by biochemical puri®cation of a 2 MDa complex containing all SWI/ SNF proteins and by co-immunoprecipitation of dierent subunits of the complex (Cairns et al., 1994; Cote et al., 1994; Wang et al., 1996a,b) . The complex also contains ATPase activity that destabilizes the interaction between DNA and histones. This would result in disruption of the chromatin and an increase in the binding of transcription factors to the DNA (Cote et al., 1994; Kwon et al., 1994; Owen-Hughes et al., 1996; Wang et al., 1996a) .
Human homologs have been found for many of the proteins in the yeast SWI/SNF complex, including the SNF5 gene, (Kalpana et al., 1994; Muchardt et al., 1995; Wang et al., 1996a) as well as the SWI3 and SWP73 genes (Wang et al., 1996b) . Two multi-protein complexes, BRG1 and hbrm, have been identi®ed as SWI2/SNF2 homologs (Khavari et al., 1993; Muchardt and Yaniv, 1993) . The complex that forms with BRG1 contains as many as 12 dierent associated proteins. The proteins in these complexes have recently been termed BAF's for`BRG1 Associated Factors' (Wang et al., 1996a,b) . To follow current terminology, hSNF5/ INI1 will be termed BAF47 in this study. The complex also contains an actin-like protein, BAF53, which helps target the BRG1 complex to the nuclear matrix (Zhao et al., 1998) .
The human SWI/SNF complex has been shown to interact with the Rb family of proteins through the E7 homology region in the BRG1 subunit. BRG1 cooperates with Rb to cause cell cycle arrest. It has been suggested the SWI/SNF facilitates Rb-E2F-mediated transcriptional repression (Dunaief et al., 1994; Trouche et al., 1997) . Therefore, disruption of the human SWI/SNF could impair the tumor suppressor function of Rb. Alternatively, disruption of the BRG1 complex could contribute to tumorigenicity by perturbing transcription of an unknown essential tumor suppressor gene.
Wilms' tumor (WT), rhabdomyosarcomas (RMS) and rhabdoid tumors are pediatric tumors mostly aecting children under 5 years of age. WT is a nephroblastoma of nephric blastema origin (McMaster et al., 1995) . RMS are soft tissue sarcomas of skeletal muscle origin that have been found in a wide range of organs including the head and neck region (Pappo, 1996; Parham, 1996) . Rhabdoid tumors are of unknown origin found most frequently in the CNS, kidney and chest wall (Biegel et al., 1999; Pogacnik and Zidar, 1997; Rosty et al., 1998; Versteege et al., 1998) . All three of these tumor types have loss of heterozygosity (LOH) at chromosome region 11p15.5 (Charles et al., 1998; Scho®eld et al., 1996; Visser et al., 1997) . Although rhabdoid tumors also display LOH at chromosome regions 22q11-12 (Scho®eld et al., 1996) , a comprehensive analysis for LOH at chromosome 22 in RMS (Visser et al., 1997) and WT has not been done.
The gene for BAF47 maps to 22q11.2, an area frequently found deleted in rhabdoid tumors. Recent studies have demonstrated mutations as well as complete deletions of the BAF47 gene in primary rhabdoid tumors and rhabdoid cell lines (Biegel et al., 1999; Rosty et al., 1998; Versteege et al., 1998) . The predicted outcome for gene mutation is expression of a truncated BAF47 protein or no protein at all. The absence of a properly formed SWI/SNF complex due to the deletion of a component BAF protein could contribute to tumorigenicity by either the lack of transcription of an unknown essential tumor suppressor gene, such as WT2 or p53, resulting from improper chromatin structure or by disruption of a necessary interaction with known tumor suppressors such as the Rb family of proteins (Dunaief et al., 1994; Trouche et al., 1997) .
In this study, we have attempted to expand on these ®ndings by screening rhabdoid cell lines as well as the two similar pediatric tumors, RMS and WT, for mutations in the BAF47 gene as well as BAF47, BRG1, and BAF53 protein expression in isolated nuclear extracts.
Results

Western blot analysis ± cell lines
For the BAF Abs tested, the Jurkat cells were used as a positive control as previously reported (Wang et al., 1996a) . None of the cell lines were negative for the BAF53, the actin related protein found in the complex (Zhao et al., 1998) . Since BAF53 was present in all samples tested, it was used as a gel loading control. All 6 rhabdoid as well as the RMS cell line A204 were negative for the BAF47 protein.
All other RMS cell lines tested were positive for the BAF47 protein, although slightly reduced in BIRCH and Rh18. In the NW LCL, D-RHA1, and Rh28F8 samples, tubulin was detected, indicating that these samples contained some cytoplasmic contamination. Therefore, the amount of nuclear protein loaded for these samples was less than 10 mg and could explain why they appear to have a reduced signal for BAF47. Both of the EBV Figure 1 Western blot analysis of cell lines. Ten mg of nuclear extracts were run in a 7.5% agarose gel at 100 V for 1.5 h. Each blot was probed with anti-BRG1, anti-BAF47 and anti-BAF53 Abs. For BAF47, no protein was detected for A-204, G401, TM87-16, TTC549, TTC642, TTC709, and TTC1240. BAF53 and BRG1 were detected for all cell lines assayed. An anti-tubulin Ab was used as a control for nuclear extract purity All PCR reactions were run using conditions previously described (Versteege et al., 1998) . No PCR product was obtained for any exon of BAF47 for G401, TM87-16, and TTC549 or exons 1 ± 5 for TTC709. Exon 1 and exon 9 are shown. b-actin is shown as a positive control immortalized lymphocytes tested were positive for the BAF47 protein (Figure 1 ).
PCR ± cell lines
We next determined if the absence of protein was due to the deletion of the BAF47 gene. Normal human placenta and ®broblasts were used as controls for each exon primer while b-actin was used as a control for each DNA sample. For three rhabdoid cell lines, G401, TTC549, and TM87-16, a PCR product was attained when the reaction was carried out with the b-actin primers but not for any of the 9 exons for BAF47. PCR products were attained for TTC709 only for exons 6 ± 9 and b-actin. PCR ampli®cation products were generated when using the other samples as DNA templates for all nine BAF47 exons and b-actin ( Figure 2 ).
Mutational analysis ± cell lines
The DNA sequence of each cell line in which the Western blot was negative for the BAF47 protein was determined. Sequence analysis of TTC642 and TTC1240 revealed a nonsense point mutation in exon 2 and exon 6 respectively. Analysis of A204 determined a 2 base deletion in exon 5 (Table 2a) . To con®rm the ability to obtain a wild-type pro®le, sequence analysis of some of the cell lines positive by PCR ampli®cation and protein analysis was also performed. TTC516, D-RHA1, and the C LCL lymphocytes possessed a wildtype pro®le for all 9 exons of the BAF47 gene.
Western blot analysis ± primary tumors
For all 18 Wilms' tumors tested, BAF47 and BAF53 were detected (Figure 3) . In a few of the samples, varying amounts of tubulin was detected, indicating that some of the samples were not pure nuclear extracts. Each tumor sample that was positive for tubulin also contained excessive blood in the original sample, which may be the cause for the cytosolic contamination. Although it is possible that the positive band for the BAF47 protein in these samples is from blood and stromal contamination, the majority of the tumors tested were positive for BAF47 and negative for tubulin. In contrast, two of the 7 RMS appeared to be missing the BAF47 protein (Figure 4) . In one sample, RMS134, tubulin was detected, indicating that the sample contained some cytoplasmic contamination.
Mutational analysis ± primary tumors
PCR was performed on some of the Wilms' tumor samples to con®rm the presence of an intact BAF47 gene. For each of the WT tested, PCR products were obtained for all of the BAF47 gene exons ( Figure 5 ). When PCR analysis was run using the RMS DNA, no alterations were detected for any of the nine BAF47 gene exons ( Figure 5 ). Sequence analysis of the WT samples revealed a wild-type product. RMS972 was found to have a base deletion in exon 3 and a base change in exon 6. All other RMS were found to have a wild-type pro®le (Table 2b) .
Southern blot analysis
To con®rm the deletion of speci®c exons found in the PCR analysis, Southern blot analysis was performed. Homozygous deletion of exons 1 ± 9 of G401, TM87-16, TTC549 and exons 1 ± 5 in TTC 709 corresponded to results obtained in the PCR analysis. TTC 709 is slightly underloaded. Birch and Rh18 demonstrated wild-type pro®le (Figure 6a ). RMS2253, which was negative in the Western yet yielded a wild-type sequence, had a rearranged exon 1 ± 5 fragment compared to normal human DNA (Figure 6b ). This was con®rmed using ®eld inversion gel electrophoresis (FIGE) to increase band resolution (Figure 6c ) demonstrating that the PCR products were either from contaminating normal tissue or a minor Figure 3 Western blot of primary Wilms' tumours. Ten mg of nuclear extracts were run in a 7.5% agarose gel at 100 V for 1.5 h. Each blot was probed with anti-BRG1, anti-BAF47 and anti-BAF53 Abs. BRG1, BAF47 and BAF53 protein was detected in all 18 primary WT assayed. An anti-tubulin Ab was used as a control for nuclear extract purity Figure 4 Western blot of primary Rhabdomyosarcomas. Ten mg of nuclear extracts were run in a 7.5% agarose gel at 100 V for 1.5 h. Each blot was probed with anti-BRG1, anti-BAF47 and anti-BAF53 Abs. For BAF47, no protein was detected for RMS972 and RMS2253. BRG1 was slightly reduced in RMS2253. BAF53 was detected in all RMS assayed. An antitubulin Ab was used as a control for nuclear extract purity Figure 5 PCR ampli®cation of BAF47 gene with primary WT and RMS DNA. All PCR reactions were run using conditions previously described (Versteege et al., 1998) . PCR products were obtained for all nine exons of BAF47. Exon 1 and exon 9 are shown. b-actin is shown as a positive control population of BAF47 wild-type tumor cells. A faint wild-type band is also detected. The origin of the crossreacting band at 7.4 Kb observed in all samples is unknown. Exon bands were assigned according to previous reports (Versteege et al., 1998) .
Western blot analysis ± BRG1
We also examined whether absence of the BAF47 protein in nuclear extracts was concurrent with absence or other complex proteins. If the BRG1 protein was missing from the nucleus, then tumors could develop through the loss of Rb function because BRG1 has been shown to interact with the Rb protein (Dunaief et al., 1994; Strober et al., 1996; Trouche et al., 1997) . The BRG1 protein was detected in all samples tested, although RMS2253 appears to have a reduced amount (Figures 1, 3 and 4) .
Discussion
Previous work has shown mutations or deletions of the BAF47 gene in both rhabdoid cell lines (Versteege et al., 1998) and in primary rhabdoid tumors (Biegel et al., 1999) . The predicted outcome for alteration of the BAF47 gene is a truncated or missing BAF47 protein.
In this study, we have tested this notion using four previously uncharacterized rhabdoid cell lines. For each of the cell lines, the gene for BAF47 was either mutated or deleted. As predicted, Western blot analysis of nuclear extracts from these cell lines was negative when probed for the BAF47 protein.
Previous studies have demonstrated that each SWI/ SNF protein is required for proper function in yeast and that this interdependence is believed to be required for proper protein complex formation (Laurent et al., 1991; Peterson and Herskowitz, 1992) . It is possible that the absence of the BAF47 protein in these cell lines could contribute to their tumorigenicity by the lack of transcription of an essential tumor suppressor gene, such as WT2 and p53, or by disruption of Rb function. The literature has shown an interaction between Rb family members and the BRG1 protein (Dunaief et al., 1994; Mittnacht and Weinberg, 1991; Strober et al., 1996; Trouche et al., 1997) . If the BRG1 complex does not properly form as a result of a missing BAF protein, it is possible that even though Rb is present in the cell, it is`functionally Rb negative'. However, we found that BRG1 was not missing in any tumor cell line tested. As further evidence that other BRG1 complex proteins exists in these cells, we also probed for the presence of BAF53 (Wang et al., 1996a) . Again, BAF53 was detected in all rhabdoid cell lines tested.
Also examined were two similar pediatric tumors, RMS and WT. Since all three pediatric tumors are known to share a similar genetic link, LOH at 11p15.5 (Charles et al., 1998; Scho®eld et al., 1996; Visser et al., 1997) , it was hypothesized that they may also share a common defect in the BAF47 gene at 22q11.2. Both were assayed for mutations in the BAF47 gene and for the presence of the BRG1, BAF47 and BAF53 proteins in isolated nuclear extracts. For the primary WT, the BAF47, BRG1 and BAF53 proteins were detected in all samples by Western blots. PCR and sequence analysis of representative samples con®rmed that the BAF47 gene was not mutated in these primary WT.
However, about 25% of the primary RMS and 10% of the RMS cell lines tested did not contain the BAF47 protein. Sequence analysis of the BAF47 gene PCR products demonstrated a mutation in at least one of the nine exons except for RMS2253. Southern blot analysis showed a partial deletion of exons 1 ± 5 in RMS2253. The PCR products and subsequent sequence analysis were the result of contaminating normal tissue and/or blood. In accordance with previously reported results (Biegel et al., 1999) , it is believed that a germ line mutation occurred in RMS972, since it has two independent mutations. We also probed the RMS samples for the presence of BRG1 and BAF53. Like the WT, BRG1 and BAF53 were detected in all cell lines and primary tumors tested. BRG1 does appear to be lower in RMS2253, which may be relevant. This again illustrates that not all of the components of the BRG1 complex are missing in these tumor samples.
Rhabdomyosarcomas have traditionally been classi®ed by histological analysis into groups with 5-year survival rates ranging from 95 ± 40%. The lowest survival rate is often associated with`rhabdoid features' (Pappo, 1996) . Rhabdoid tumors are highly malignant and have an extremely poor prognosis (Pogacnik and Zidar, 1997) . In contrast, WT generally have an excellent prognosis with high sensitivity to radiation and chemotherapy (Green et al., 1997) . This may correlate with the apparent lack of BAF47 mutations. Therefore, alteration of BAF47 may be a genetic marker associated with this poor prognosis and, if so, could be used as an early sign that extensive therapy should be initiated.
In this study, we have demonstrated that rhabdoid tumors and some RMS share a common genetic defect, mutation in the BAF47 gene located at chromosome 22q11.2. To our knowledge, this study represents the ®rst demonstration of this genetic link between rhabdoid tumors and RMS but not with WT. Not all of the proteins of the BRG1 complex are missing in these tumors since BRG1 and BAF53 are present in all samples tested. Since it has been shown that deletion of just one member of the SWI/SNF complex in yeast is sucient to inactivate the complex (Peterson and Herskowitz, 1992) (Laurent et al., 1991) , the question of whether there is an alteration of one or more of the other components of the BRG1 complex in WT is an interesting one that deserves future examination.
Materials and methods
Cell lines
All cell lines were grown in RPMI with 10 ± 20% FCS until con¯uence was reached. The rhabdoid cell lines TTC549, TTC642, TTC709 and TTC1240 as well as the embryonal RMS cell lines TTC445, TTC516, Birch, TM87-16, and SCS CTR were the generous gift of Dr Timothy Triche, Children's Hospital of Los Angeles. The alveolar RMS cell line D-RHA1 was obtained from Dr Will Benedict at M.D. Anderson Cancer Center. Rh18, Rh28F was obtained from Dr Peter Houghton at St. Judes Hospital. C LCL, the EBV immortalized lymphocytes from a rhabdoid patient, and NW LCL, a split hand/split foot patient used as an EBV immortalized lymphocyte control were developed in our laboratory. All other cell lines were obtained from the American Type Culture Collection, MD. (Table 1) .
Primary tumors
The primary Wilms' and rhabdomyosarcoma tumors were the generous gift of Dr Timothy Triche, Children's Hospital, Los Angeles, CA and Dr Perry Nisen, UT-Southwestern Medical Center, Dallas, TX.
Isolation of nuclear protein
For primary tumors, samples were crushed into a ®ne powder under liquid nitrogen and ground into a slurry with a dounce and a 0.3 M sucrose buer containing 0.1% NP-40. The nuclear pellet was obtained by centrifugation and washed twice in buer without NP-40, ®rst with a 0.7 M sucrose buer then with a 1.0 M sucrose buer. The nuclear protein was isolated from the nuclear pellet with a high salt buer (400 mM NaCl) containing the reducing agent dithiothreitol and the protease inhibitors pepstatin A, phenylmethylsulfonyl uoride, leupeptin, and aprotinin. The Bradford protein assay was used to determine protein concentration. The same procedure was carried out for each of the cell lines except for the use of the dounce.
Western blot analysis
Between 5 and 10 mg of nuclear protein of each sample was run in a Fisher pre-cast 7.5% gel for 1.5 h at a constant voltage of 100 V. The gel was transferred to a Millipore Immobilon-P membrane for 16 ± 18 h at a constant current of 80 mA. The primary antibodies, anti-BRG1, anti-BAF47 and anti-BAF53 have been previously described (Wang et al., 1996a) . The anti-tubulin antibody, which was used to determine the purity of the nuclear extracts, was purchased from Sigma. All secondary Abs used, anti-mouse and antirabbit, were obtained from Amersham Life Sciences. All Western blots were developed on either Kodak MR or Kodak AR ®lm.
DNA isolation and PCR ampli®cation
Cell line and tumor genetic DNA was isolated using the ScotLab Genomic DNA Isolation Kit from Amersham Life Sciences. PCR was performed using the EasyStart 50 PCR Kit (Molecular Bio-Products Inc.) using conditions previously described (Versteege et al., 1998) . Each exon was ampli®ed individually using primers located in the introns. The primer sequences used were the generous gift of Dr Olivier Delattre, Institut Curie, Paris.
Mutational analysis
Both strands of the BAF47 coding sequence was completely analysed for each cell line and tumor. PCR products were puri®ed using the QIAquick PCR Puri®cation Kit (Qiagen Inc.) and directly sequenced. Sequencing was performed at the UNC-CH Automated DNA Sequencing Facility on a Model 377 DNA Sequencer (Perkin Elmer, Applied Biosystems Division) using the ABI PRISM TM Dye Terminator Cycle Sequencing Ready Reaction Kit with AmpliTaq DNA Polymerase, FS (Perkin Elmer, Applied Biosystems Division).
Southern blot analysis
Five mg of genomic DNA were digested with EcoRI, separated by electrophoresis in a 0.8% agarose gel (1% for FIGE) and transferred to a positively charged membrane (Boehringer Mannheim) using standard protocols. BAF47 cDNA probes were 32 P-labeled using a random-primed kit (Promega) and hybridized overnight at 428C in a 50% formamide solution. Following hybridization, blots were washed to high stringency and exposed to X-ray ®lm (Kodak).
